Ceesay Abraham
Reporting owner on Forms 3, 4 and 5, CIK 1722140.
Ceesay Abraham reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-08.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| RAPP · Rapport Therapeutics, Inc.CIK 2012593 | director, officer (Chief Executive Officer) | 1 | 2026-10-08 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| RAPP · Rapport Therapeutics, Inc.Common Stock | 2026-10-07 | S sold | -1,147 | $30.66 | 452,245 | Form 4 |
| RAPP · Rapport Therapeutics, Inc.Common Stock | 2026-10-06 | S sold | -3,375 | $32.0314 | 453,392 | Form 4 |
| RAPP · Rapport Therapeutics, Inc.Common Stock, holding | 81,729 | Form 4 | ||||
| RAPP · Rapport Therapeutics, Inc.Common Stock, holding | 20,729 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001193125-26-417919 | Rapport Therapeutics, Inc. | 2026-10-08 |